The PKR kinase promoter binds both Sp1 and Sp3, but only Sp3 functions as part of the interferon-inducible complex with ISGF-3 proteins

Virology

Volumn 313, Issue 2, 2003, Pages 553-566

  Ward, Simone Visosky ^a   Samuel, Charles E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 9; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN; PROTEIN ISGF 3; PROTEIN SP3; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME BINDING; ENZYME REGULATION; GEL MOBILITY SHIFT ASSAY; GENE; GENE FUNCTION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; IMMUNOPRECIPITATION; PKR GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION;

EID: 0042887627     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00347-7     Document Type: Article

References (53)

1. Barber G.N., Wambach M., Wong M.L., Dever T.E., Hinnebusch A.G., Katze M.G. Translational regulation by the interferon-induced double-stranded-RNA-activated 68-kDa protein kinase. Proc. Natl. Acad. Sci. USA. 90:1993;4621-4625.
2. Benkirane M., Neurveut C., Chun R.F., Smith S.M., Samuel C.E., Gatignol A., Jeang K.-T. Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with the RNA-dependent protein kinase PKR. EMBO J. 16:1997;611-624.
3. Biggin M.D. Ultraviolet cross-linking assay to measure sequence-specific DNA binding in vivo. Methods Enzymol. 304:1999;496-515.
4. Biron, C.A., Sen, G.C., 2001. Interferons and other cytokines, in: Fields Virology, fourth ed., Chapter 12, Lippincott-Raven, Philadelphia, pp. 321-351.
5. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., Darnell J.E. Jr. Stat3 as an oncogene. Cell. 98:1999;295-303.
6. Clayton A.L., Rose S., Barratt M.J., Mahadevan L.C. Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation. EMBO J. 19:2000;3714-3726.
7. Clemens M.J., Elia A. The double-stranded RNA-dependent protein kinase PKR structure and function . J. Interferon Cytokine Res. 17:1997;503-524.
8. Cosentino G.P., Venkatesan S., Serluca F.C., Green S.R., Mathews M.B., Sonenberg N. Double-stranded RNA-dependent protein kinase and TAR-RNA binding protein form homo- and heterodimers in vivo. Proc. Natl. Acad. Sci. USA. 92:1995;9445-9449.
9. Fu X.-Y., Kessler D.S., Veals S.A., Levy D.E., Darnell J.E. Jr. ISGF3, the transcriptional activator induced by interferon α, consists of multiple interacting polypeptide chains. Proc. Natl. Acad. Sci. USA. 87:1990;8555-8559.
10. Gale M. Jr., Tan S.-L., Katze M.G. Translational control of viral gene expression in eukaryotes. Microbiol. Mol. Biol. Rev. 64:2000;239-280.
11. George C.X., Samuel C.E. Characterization of the 5′-flanking region of the human RNA-specific adenosine deaminase ADAR1 gene and identification of an interferon-inducible ADAR1 promoter. Gene. 229:1999;203-213.
12. Hagen G., Müller S., Beato M., Suske G. Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J. 13:1994;3843-3851.
13. Horvath C.M. STAT proteins and transcriptional responses to extracellular signals. Trends Biochem. Sci. 25:2000;496-502.
14. Huang M., Qian F., Hu Y., Ang C., Li Z., Wen Z. Chromatin-remodelling factor BRG1 selectively activates a subset of interferon-alpha-inducible genes. Nat. Cell. Biol. 4:2002;774-781.
15. Kingsley C., Winoto A. Cloning of GT box-binding proteins a novel Sp1 multigene family regulating T-cell receptor gene expression . Mol. Cell. Biol. 10:1992;4251-4261.
16. Kisseleva T., Bhattacharya S., Schindler C.W. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene. 285:2002;1-24.
17. Kostura M., Mathews M.B. Purification and activation of the double-stranded RNA-dependent eIF-2 kinase DAI. Mol. Cell. Biol. 9:1989;1576-1586.
18. Kuhen K.L., Samuel C.E. Isolation of the interferon-inducible RNA-dependent protein kinase Pkr promoter and identification of a novel DNA element within the 5′-flanking region of the human and mouse Pkr genes. Virology. 227:1997;119-130.
19. Kuhen K.L., Samuel C.E. Mechanism of interferon action. Functional characterization of positive and negative regulatory domains that modulate transcriptional activation of the human RNA-dependent protein kinase Pkr promoter. Virology. 254:1999;182-195.
20. Kuhen K.L., Vessey J.W., Samuel C.E. Mechanism of interferon action. Identification of essential positions within the novel 15-base-pair KCS element required for transcriptional activation of the RNA-dependent protein kinase Pkr gene. J. Virol. 72:1998;9934-9939.
21. Lania L., Majello B., de Luca P. Transcriptional regulation by the Sp family proteins. Int. J. Biochem. Cell Biol. 29:1997;1313-1323.
22. Lee T.G., Tang N., Thompson S., Miller J., Katze M.G. The 58, 000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins. Mol. Cell. Biol. 14:1994;2331-2342.
23. Lengyel P. Tumor-suppressor genes news about the interferon connection . Proc. Natl. Acad. Sci. USA. 90:1993;5893-5895.
24. Levy D.E., Darnell J.E. Jr. Signalling STATs: transcriptional control and biological impact . Nat. Rev. Mol. Cell. Biol. 3:2002;651-652.
25. Levy D.E., Lew D.J., Decker T., Kessler D.S., Darnell J.E. Jr. Synergistic interaction between interferon-α and interferon-γ through induced synthesis of one subunit of the transcription factor ISGF3. EMBO J. 9:1990;1105-1111.
26. Look D.C., Pelletier M.R., Tidwell R.M., Roswit W.T., Holtzman M.J. Stat1 depends on transcriptional synergy with Sp1. J. Biol. Chem. 270:1995;30264-30267.
27. Luthman H., Magnusson G. High efficiency polyoma DNA transfection of chloroquine treated cells. Nucleic Acids Res. 11:1983;1295-1308.
28. Meurs E., Chong K., Galabru J., Thomas N.S., Kerr I.M., Williams B.R.G., Hovanessian A.G. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell. 62:1990;379-390.
29. Miyamoto M., Fujita T., Kimura Y., Maruyama M., Harada H., Sudo Y., Miyata M., Taniguchi T. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements. Cell. 54:1988;903-913.
30. Orlando V., Strutt H., Paro R. Analysis of chromatin structure by in vivo formaldehyde crosslinking. Methods. 11:1997;205-214.
31. Ortega L.G., McCotter M.D., Henry G.L., McCormack S.J., Thomis D.C., Samuel C.E. Mechanism of interferon action. Biochemical and genetic evidence for the intermolecular association of the RNA-dependent protein kinase PKR from human cells. Virology. 215:1996;31-39.
32. Patel R.C., Stanton P., Mc Millan N.M.J., Williams B.R.G., Sen G.C. The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo. Proc. Natl. Acad. Sci. USA. 92:1996;8283-8287.
33. Patel R.C., Stanton P., Sen G.C. Specific mutations near the amino terminus of double-stranded RNA-dependent protein kinase (PKR) differentially affect its double-stranded RNA binding and dimerization properties. J. Biol. Chem. 271:1996;25657-25663.
34. Pathak V.K., Schindler D., Hershey J.W.B. Generation of a mutant form of protein synthesis initiation factor eIF-2 lacking the site of phosphorylation by eIF-2 kinases. Mol. Cell. Biol. 8:1988;993-995.
35. Paulson M., Press C., Smith E., Tanese T., Levy D.E. IFN-stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff. Nat. Cell Biol. 4:2002;140-147.
36. Philipsen S., Suske G. A tale of three fingers the family of mammalian Sp/XKLF transcription factors . Nucleic Acids Res. 27:1999;2991-3000.
37. Qureshi S.A., Salditt-Georgieff M., Darnell J.E. Jr. Tyrosine-phosphorylated Stat1 and Stat2 plus a 48-kDa protein all contact DNA in forming interferon-stimulated-gene factor 3. Proc. Natl. Acad. Sci. USA. 92:1995;3829-3833.
38. Romano P.R., Garcia-Barrio M.T., Zhang X., Wang Q., Taylor D.R., Zhang F., Herring C., Mathews M.B., Qin J., Hinnebusch A.G. Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2 alpha kinases PKR and GCN2. Mol. Cell. Biol. 18:1998;2282-2297.
39. Samuel C.E. Mechanism of interferon action. Phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase possessing site specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc. Natl. Acad. Sci. USA. 76:1979;600-604.
40. Samuel C.E. The eIF-2α protein kinases, regulators of translation in eukaryotes from yeast to humans. J. Biol. Chem. 268:1993;7603-7606.
41. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:2001;778-809.
42. Samuel C.E., Knutson G.S. Mechanism of interferon action human leukocyte and immune interferons regulate the expression of different genes and induce different antiviral states in human amnion U cells . Virology. 130:1983;474-484.
43. Schindler C., Fu X.-Y., Improta T., Aebersold R., Darnell J.E. Jr. Proteins of transcription factor ISGF-3 one gene encodes the 91- and 84-kDa ISGF-3 proteins that are activated by interferon α Proc. Natl. Acad. Sci. USA. 89:1992;7836-7839.
44. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67:1998;227-264.
45. Suske G. The Sp-family of transcription factors. Gene. 238:1999;291-300.
46. Tanaka H., Samuel C.E. Mechanism of interferon action. Structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA. 91:1994;7995-7999.
47. Takahashi, K., Saitoh, S., Yanagida, M., 2000. Application of the chromatin immunoprecipitation method to identify in vivo protein-DNA associations in fission yeast. Science's STKE, www.stke.org/cgi.content/full/OC_sigtrans;56/pI1.
48. Thomis D.C., Doohan J.P., Samuel C.E. Mechanism of interferon action cDNA structure, expression and regulation of the interferon-induced, RNA-dependent P1/eIF-2α protein kinase from human cells . Virology. 188:1992;33-46.
49. Thomis D.C., Samuel C.E. Mechanism of interferon action autoregulation of RNA-dependent P1/eIF-2α protein kinase (PKR) expression in transfected mammalian cells . Proc. Natl. Acad. Sci. USA. 89:1992;10837-10841.
50. Thomis D.C., Samuel C.E. Mechanism of interferon action evidence for intermolecular autophosphorylation and autoactivation of the interferon-induced, RNA-dependent protein kinase PKR . J. Virol. 67:1993;7695-7700.
51. Toth J., Biggin M.D. The specificity of protein-DNA crosslinking by formaldehyde in vitro and in Drosophila embryos . Nucleic Acids Res. 28:2000;e4. i-viii.
52. Ward S.V., Samuel C.E. Regulation of the interferon-inducible PKR kinase gene the KCS element is a constitutive promoter element that functions in concert with the interferon-stimulated response element . Virology. 296:2002;136-146.
53. Zhou Z.-H.L., Chaturvedi P., Han Y., Aras S., Li Y., Kolattukudy P., Ping D., Boss J.M., Ransohoff R.M. IFN-γ induction of the human monocyte chemoattractant protein (hMCP)-1 gene in astrocytoma cells functional interaction between an IFN-γ-activated site and a GC-rich element . J. Immunol. 160:1998;3908-3916.